Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675510 | PMC |
| http://dx.doi.org/10.4103/ijo.IJO_1547_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transforming Healthcare: Artificial Intelligence (AI) Applications in Medical Imaging and Drug Response Prediction.
Genome Integr
January 2025
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Artificial intelligence (AI) offers a broad range of enhancements in medicine. Machine learning and deep learning techniques have shown significant potential in improving diagnosis and treatment outcomes, from assisting clinicians in diagnosing medical images to ascertaining effective drugs for a specific disease. Despite the prospective benefits, adopting AI in clinical settings requires careful consideration, particularly concerning data generalisation and model explainability.
View Article and Find Full Text PDFSemaglutide, type 2 diabetes, and the risk of nonarteritic anterior ischemic optic neuropathy.
Int J Retina Vitreous
January 2025
Brazilian Diabetes Society, São Paulo, Brazil.
In the last months, conflicting evidence on a possible association between the use of semaglutide and incident nonarteritic anterior ischemic optic neuropathy (NAION) has emerged. A recently published study, which evaluated all patients with type 2 diabetes in Denmark, has shown with robustness that once-weekly semaglutide doubles the five-year risk of NAION. In this comment, the new evidence is discussed, along with practical implications for type 2 diabetes patients.
View Article and Find Full Text PDFMeaning making and fostering radical hope: applying positive psychology to eco-anxiety research in youth.
Front Child Adolesc Psychiatry
February 2024
Psychology Department, University of Bath, Bath, United Kingdom.
The consequences of human activity on climate change are increasingly apparent. For example, they are causing ecological degradation and affecting human and animal health. Rightly so, it is considered as the most important challenge of this century.
View Article and Find Full Text PDFBeyond the : Clinician Educational Interventions May Not Be Enough to Decrease Rates of Low-Value Spinal Imaging.
AJR Am J Roentgenol
January 2025
Assistant Professor, Department of Radiology and Imaging Sciences, University of Utah Health Sciences Center.
Beyond Longer Intervals: Advocating for Regular Treatment of Neovascular AMD.
J Clin Med
December 2024
Division of Ophthalmology, Department of Surgery, UMass Chan-Lahey School of Medicine, Burlington, MA 01805, USA.
Personalizing the management of neovascular age-related macular degeneration (nAMD) poses significant challenges for practicing retina specialists and their patients. This commentary addresses some of these complexities, particularly those that arise in the context of an expanding array of intravitreal agents targeting vascular endothelial growth factor (VEGF) and related retinal disease targets. Many of these newer agents approved by the Food and Drug Administration (FDA) for the treatment of nAMD have labeling that indicates that they can provide non-inferior visual outcomes when compared head-to-head with previously available treatments and can be used at significantly extended dosing intervals in some patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!